---  
layout: startup_page  
title: "Nocion Therapeutics"  
id: "nociontx.com"  
permalink: "/nociontherapeuticsnociontx.com03042024/"  
website: "https://www.nociontx.com/"  
funding_round: "Series B"  
funding_amount: "$62M"  
investors: "Arkin Bio Capital, Monograph Capital, Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission BioCapital, Osage University Partners"  
about: "Nocion Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule sodium channel blockers (CSCBs) to treat serious conditions involving cough, itch, and pain. Their lead program, Taplucanium, is a dry powder for inhalation targeting chronic cough. The company's mission is to alleviate suffering from conditions arising from activated sensory neurons."  
markets: "Biotechnology, Health Care, Medical, Biopharmaceutical, Healthtech"  
hq: "Watertown, Massachusetts, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/nocion-therapeutics-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nocion-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/266656-87"  

date_display: "04-Mar-2024"  
date: "2024-03-04"

# SEO Optimization  
meta_title: "Nocion Therapeutics - Series B Funding ($62M)"  
meta_description: "Nocion Therapeutics, Nocion Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule sodium channel blockers (CSCBs) to treat serious con..."  
meta_keywords: "Nocion Therapeutics, Biotechnology, Health Care, Medical, Biopharmaceutical, Healthtech, Series B funding"  
canonical_url: "https://startup.projectstartups.com/nociontherapeuticsnociontx.com03042024/"  
---